Danazol for Treatment of Cytopenias in Patients With Cirrhosis
Condition(s):Cirrhosis, Liver; CytopeniaLast Updated:April 21, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Cirrhosis, Liver; CytopeniaLast Updated:April 21, 2023Recruiting
Condition(s):EndometriosisLast Updated:June 12, 2020Completed
Condition(s):Immune Thrombocytopenia; Blood Coagulation Disorders; Thrombocytopenia; Physiological Effects of DrugsLast Updated:April 29, 2022Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:July 22, 2022Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:February 28, 2020Unknown status
Condition(s):Telomere Shortening; Telomere Length, Mean LeukocyteLast Updated:October 18, 2018Unknown status
Condition(s):Immune ThrombocytopeniaLast Updated:June 13, 2023Recruiting
Condition(s):ITP; Immune ThrombocytopeniaLast Updated:May 2, 2022Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:August 9, 2022Not yet recruiting
Condition(s):Fanconi Anemia; Dyskeratosis CongenitaLast Updated:February 19, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.